158 related articles for article (PubMed ID: 6406602)
1. Detection of IgD 'hidden' lambda light chain.
Spira G; Silvian I; Tatarsky I; Carter A
J Immunol Methods; 1983 May; 60(1-2):207-12. PubMed ID: 6406602
[TBL] [Abstract][Full Text] [Related]
2. IgD myeloma protein with "unreactive" light chain determinants.
Cejka J; Kithier K
Clin Chem; 1979 Aug; 25(8):1495-8. PubMed ID: 88283
[TBL] [Abstract][Full Text] [Related]
3. Characterization of IgD. I. Isolation of two molecular forms from human serum.
Corte G; Tonda P; Cosulich E; Milstein CP; Bargellesi A; Ferrarini M
Scand J Immunol; 1979; 9(2):141-9. PubMed ID: 85332
[TBL] [Abstract][Full Text] [Related]
4. Spontaneous enzymatic cleavage of IgD myeloma protein giving a pattern of delta heavy chain disease.
Rabhi H; Ghaffor M; Abbadi MC
Arch Inst Pasteur Alger; 1989; 57():135-40. PubMed ID: 2518742
[TBL] [Abstract][Full Text] [Related]
5. IgD-lambda myeloma with separate heavy- and light-chain M-components.
Vilpo JA; Irjala K
Clin Chem; 1980 Nov; 26(12):1760-1. PubMed ID: 6775847
[No Abstract] [Full Text] [Related]
6. Immunochemical studies on heterogeneity of IgD myeloma proteins.
Ohtani H; Sakaguchi K; Saito M
Immunology; 1981 Aug; 43(4):717-22. PubMed ID: 6168563
[TBL] [Abstract][Full Text] [Related]
7. [IgD myeloma. Considerations about its diagnosis based on three cases (author's transl)].
López-Aldeguer J; Redón J; González-Molina J; Benedito M; Herranz C; Lacruz J; Navarro JR; Caballero M
Sangre (Barc); 1981; 26(6):1139-44. PubMed ID: 6805083
[No Abstract] [Full Text] [Related]
8. Interpretation Difficulties of Serum Immunofixation Test in Immunoglobulin D Multiple Myeloma with Hidden Lambda Light Chains.
Biaz A; Uwingabiye J; Rachid A; Dami A; Bouhsain S; Ouzzif Z; Idrissi SEM
Clin Lab; 2018 Jun; 64(6):1065-1069. PubMed ID: 29945318
[TBL] [Abstract][Full Text] [Related]
9. IgD-secreting murine plasmacytomas: identification and partial characterization of two IgD myeloma proteins.
Finkelman FD; Kessler SW; Mushinski JF; Potter M
J Immunol; 1981 Feb; 126(2):680-7. PubMed ID: 6778922
[TBL] [Abstract][Full Text] [Related]
10. Use of immunoglobulin heavy- and light-chain measurements compared with existing techniques as a means of typing monoclonal immunoglobulins.
Whicher JT; Wallage M; Fifield R
Clin Chem; 1987 Oct; 33(10):1771-3. PubMed ID: 3117430
[TBL] [Abstract][Full Text] [Related]
11. [A case of IgD-lambda type multiple myeloma with pyroglobulinemia].
Ohno T; Seko S; Tamegai M; Okada T; Morita T; Furukawa H; Horii S; Kanoh T
Nihon Naika Gakkai Zasshi; 1984 Jul; 73(7):980-5. PubMed ID: 6436415
[No Abstract] [Full Text] [Related]
12. [An autopsied case of IgD. lambda Myeloma with a longer survival time (author's transl)].
Yamaguchi Y; Sawamura O; Nawata Y; Hirano Y; Kato N; Nishimoto S; Tominaga K
Rinsho Ketsueki; 1979 Feb; 20(2):140-7. PubMed ID: 108431
[No Abstract] [Full Text] [Related]
13. [Immunoglobulin D. Physiology and pathology excluding myeloma].
Alcalay M; Reboux JF; Becq-Giraudon B; Bontoux D
Pathol Biol (Paris); 1975 Apr; 23(4):315-21. PubMed ID: 807900
[TBL] [Abstract][Full Text] [Related]
14. Lack of isotype exclusion and expression of aberrant lambda light chain on secreted MOPC-315 myeloma proteins.
Ju ST; Pinto D; Dorf ME
Mol Immunol; 1986 Jan; 23(1):79-85. PubMed ID: 3083241
[TBL] [Abstract][Full Text] [Related]
15. IgD amyloid in IgD-lambda monoclonal conjunctival amyloidosis. A case report.
Schaldenbrand JD; Keren DF
Arch Pathol Lab Med; 1983 Dec; 107(12):626-8. PubMed ID: 6416220
[TBL] [Abstract][Full Text] [Related]
16. Multiple myeloma with monoclonal IgG and IgD of lambda type exhibiting, under treatment, a shift from mainly IgG to mainly IgD.
Gallart T; Bladé J; Martínez-Quesada J; Sierra J; Rozman C; Vives J
Immunology; 1985 May; 55(1):45-57. PubMed ID: 3922877
[TBL] [Abstract][Full Text] [Related]
17. Immunochemical analysis of IgD-lambda paraprotein in myeloma.
Tichý M; Hrncír Z; Pola V; Mazák J
Neoplasma; 1974; 21(4):487-91. PubMed ID: 4215041
[No Abstract] [Full Text] [Related]
18. [A case of IgD (lambda)-multiple myeloma presenting as a tonsillar tumor, characterized by various kinds of inclusions in the tumor cells as an initial manifestation].
Nesumi N; Nagata I; Morinaka S; Kanoh T
Nihon Naika Gakkai Zasshi; 1985 Apr; 74(4):440-5. PubMed ID: 2995518
[No Abstract] [Full Text] [Related]
19. Human myeloma light chains with increased molecular weight: high frequency among lambda chains.
Bouvet JP; Pillot J; Liacopoulos P
Mol Immunol; 1983 Apr; 20(4):397-407. PubMed ID: 6408400
[TBL] [Abstract][Full Text] [Related]
20. [Clinicopathological studies on monoclonal IgD immunoglobulinemia; clinical difference between two different groups divided with the IgD-Fc antigenicity].
Uehara K; Ohtani H; Koide A; Saito M; Takano K
Rinsho Byori; 1982 Sep; 30(9):1008-12. PubMed ID: 6184503
[No Abstract] [Full Text] [Related]
[Next] [New Search]
